Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · IEX Real-Time Price · USD
6.74
-0.41 (-5.73%)
Jun 20, 2024, 2:32 PM EDT - Market open

Burning Rock Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Net Income
-653.69-971.23-796.7-471.92-334.17
Upgrade
Depreciation & Amortization
133.4124.147.7733.3131.36
Upgrade
Share-Based Compensation
260.72326.78282.43173.2222.79
Upgrade
Other Operating Activities
3.7963.55-11.39127.16-113.04
Upgrade
Operating Cash Flow
-255.78-456.81-477.89-73.54-228.04
Upgrade
Capital Expenditures
-8.02-67.88-210.35-74.93-45.24
Upgrade
Change in Investments
060.6294.58-30.42-301.02
Upgrade
Other Investing Activities
-1.28-0.19-2.53-3.97-0.4
Upgrade
Investing Cash Flow
-9.3-7.4681.7-109.31-346.66
Upgrade
Share Issuance / Repurchase
-48.83-83.87-8.091,920-3.64
Upgrade
Debt Issued / Paid
0-2.37-44.81-20.59-81.6
Upgrade
Other Financing Activities
---266.47656.97
Upgrade
Financing Cash Flow
-48.83-86.24-52.92,166571.74
Upgrade
Exchange Rate Effect
3.8636.67-37.01-155.95.88
Upgrade
Net Cash Flow
-310.05-513.84-486.091,8272.91
Upgrade
Free Cash Flow
-263.8-524.68-688.24-148.47-273.28
Upgrade
Free Cash Flow Margin
-49.09%-93.15%-135.52%-34.54%-71.60%
Upgrade
Free Cash Flow Per Share
-25.76-50.49-66.05-21.63-111.83
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).